about
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsInhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian DrugsModeling human influenza infection in the laboratoryRespiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?Viral Membrane Channels: Role and Function in the Virus Life CycleNeuraminidase inhibitors for influenza B virus infection: efficacy and resistanceTamiflu-resistant but HA-mediated cell-to-cell transmission through apical membranes of cell-associated influenza virusesOn the entry of Semliki forest virus into BHK-21 cellsInhibition of dengue virus replication by amantadine hydrochlorideSolution NMR structure of the V27A drug resistant mutant of influenza A M2 channelStructural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza virusesUnusual architecture of the p7 channel from hepatitis C virusProbing Lipophilic Adamantyl Group as the P1-Ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-ray Structural Studies, and Biological EvaluationApproved Antiviral Drugs over the Past 50 YearsMicrobe HuntingCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugsInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceVisual hallucinations and delirium during treatment with amantadine (Symmetrel)Activity of selenazofurin against influenza A and B viruses in vitroIn vitro antiviral activity and preliminary clinical trials of a new adamantane compoundSuppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in miceProtection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trialThe prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virusEfficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza virusesIdentification of a PA-binding peptide with inhibitory activity against influenza A and B virus replicationPrevention and treatment of influenza with hyperimmune bovine colostrum antibodyChemotherapeuticsIntranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5.Continuing challenges in influenza.From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Mast cells and influenza a virus: association with allergic responses and beyond.Zanamivir-resistant influenza viruses with a novel neuraminidase mutationAvian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses.Networks of Host Factors that Interact with NS1 Protein of Influenza A VirusBench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivoPassive immune neutralization strategies for prevention and control of influenza A infections.Emerging antiviral strategies to interfere with influenza virus entry.
P2860
Q22305941-1A84A85A-1412-4FF2-88D2-17BA2FD0BEB7Q24273361-07C3F442-6840-43B8-B20D-C3FAC47C5E9BQ26781842-E04830BC-7E16-4F12-B564-436EF9DB4299Q26796151-94B046FD-C258-45A1-A555-ABD75E8DE4FDQ27000898-E2605F00-DA44-4F0D-B1F8-EF7E1067A486Q27021579-3AE6B22F-0DE7-46ED-8C7A-13AF0CF8F8FEQ27311553-C4EED2DF-370A-4DF6-9FF9-8F5E929185A4Q27482326-051314FA-634D-4DC6-AC8C-13AE28ABB90DQ27491277-21D5EC9F-9C3C-49B3-A082-38D5B43AD14CQ27664419-B940B605-FEEA-4BD3-9C05-E6B8EE01895AQ27675528-30899F97-F2F8-4878-9EDE-1FF7A9A66BB4Q27678504-E72A1202-65D4-4F5B-85D9-C57D3DE98763Q27717366-6BC2D0E3-7931-4E8E-A734-95E71D76B236Q27755387-C4AB2E6C-740A-49F9-9E8C-456B9E11158AQ27890382-5585F1DD-94B3-408F-8A53-3001CE5BE1CFQ28085400-DD440B31-4ADE-4296-9040-3214EC8D2D1EQ28282405-E0B95B7B-5DE5-4122-92C0-26A06EBC9C43Q28319393-97D5D9C5-7268-4D31-AC42-EDB4281511B7Q28362680-CE52D115-7D89-464A-8A93-3AF8FD2D1083Q28363167-54AB3365-2038-4ECD-BD8F-A1B6EB9B7AC6Q28364122-CBCB4951-4811-46EB-AB43-8279BE32771DQ28364287-EB2E685C-5FD3-48B9-AB13-A30D29F29A60Q28365144-80A1052C-6131-493F-B5D5-2CF4E5EDC31DQ28379492-4EC1D7DA-0362-4945-AF98-B53386CBF766Q28473051-122E4C73-BB69-4CB3-8613-E00633C65A0EQ28476315-625865ED-FA49-45E6-99A6-E556770AA386Q28748705-6883B2F1-7BDB-4D8D-8DD1-4AD84C5653D0Q30047670-AC5829FB-9928-4E38-B42A-7DFE3787EA6DQ30356284-2124EA34-26BA-4F26-B989-A4255D164E02Q30363190-4926D237-F866-4101-A9BF-D13AB67F89F5Q30363724-7971B1C6-4393-4655-A9B2-F24C25F510FFQ30375297-E35CE4FC-04B7-4350-99D9-FCA2C0379FB7Q30379353-A1FC36AD-EED1-4A5C-BC29-7FF7950E7CDBQ30386911-349BC88C-EBF4-4153-9D26-21AE34D65A3FQ30388331-8E78916E-B563-47C8-8FEE-290F5D4C7D1CQ30389010-B63C8ECB-D2E3-4AA6-861D-BAF6F5A3D0D0Q30392198-2FA9D922-6111-4D75-B306-5A2D09836EFCQ30404138-CCCC290C-9921-47A7-83E5-5AA6E1D25FC8Q30413158-91117304-9BD8-4827-8ACB-F4D0BA752D76Q30432421-9F57E07E-E5DB-40A0-B824-33A7BA29536B
P2860
description
1964 nî lūn-bûn
@nan
1964年の論文
@ja
1964年学术文章
@wuu
1964年学术文章
@zh
1964年学术文章
@zh-cn
1964年学术文章
@zh-hans
1964年学术文章
@zh-my
1964年学术文章
@zh-sg
1964年學術文章
@yue
1964年學術文章
@zh-hant
name
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).
@en
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE
@nl
type
label
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).
@en
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE
@nl
prefLabel
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).
@en
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE
@nl
P2093
P1433
P1476
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).
@en
P2093
GRUNERT RR
HERMANN EC
HOFFMANN CE
MCGAHEN JW
NEUMAYER EM
PAULSHOCK M
P304
P356
10.1126/SCIENCE.144.3620.862
P407
P577
1964-05-01T00:00:00Z